Patel Naimish
- SEC CIK
- 0002021679
In the past year, 1 open-market purchase filing worth $49.7K and 2 sale filings worth $362.6K.
Current role at each company
- AGMB AgomAb Therapeutics NVDirectoras of Sep 15, 2026
- CRSP CRISPR Therapeutics AGChief Medical Officeras of Jun 2, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $49.7K
- 1 filing
- Sold
- $362.6K
- 2 filings
- Net
- −$312.9K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Patel Naimish as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CRSP CRISPR Therapeutics AG
Chief Medical Officer4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 1, 2026 (view filing) | May 29 | 3 days | Patel NaimishChief Medical Officer | SSale | −3.79K | $55.62 | −$210.6K | −16.4%19.4K after | |
| Mar 17, 2026 (view filing) | Mar 16 | 1 day | Patel NaimishChief Medical Officer | SSale | −3.15K | $48.26 | −$152.0K | −19.3%13.1K after | |
| Jan 27, 2026 (view filing) | Apr 3, 2025 | 299 daysLate | Patel NaimishChief Medical Officer | PPurchase | +1.51K | $32.96 | +$49.7K | New position1.51K after | |
| May 30, 2025 (view filing) | May 29 | 1 day | Patel NaimishChief Medical Officer | SSale | −3.93K | $35.94 | −$141.3K | −39.3%6.07K after |